Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Papillomavirus Infections 1Human Papillomavirus-Related Cervical Carcinoma 1

Interventions

Specimen Handling 5Human Papillomavirus Recombinant Vaccine nonavalent 4Papillomavirus Vaccines 3Human Papillomavirus DNA Tests 3Colposcopy 3Radiotherapy, Intensity-Modulated 2Methods 2Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2Early Intervention, Educational 2Cisplatin 2human papillomavirus vaccine, L1 type 16, 18 1artesunic acid 1artenimol 1artemisinin 1adacel 1Vaccines 1Tetanus Toxoid 1Sodium Chloride 1Platinum 1Patient Navigation 1Nimorazole 1Mass Screening 1Interviews as Topic 1Injections 1High-Energy Shock Waves 1Educational Status 1Diphtheria-Tetanus-acellular Pertussis Vaccines 1Diphtheria Toxoid 1Clinical Protocols 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Papillomavirus Infections × Diphtheria Toxoid × Clear all
NCT03180034 2025-09-04

ESCUDDO

National Cancer Institute (NCI)

Phase 4 Active not recruiting
27,945 enrolled

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡